Expanded Access Type
Expanded access type describes the category of expanded access under Food and Drug Administration regulations.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
Expanded access type describes the category of expanded access under Food and Drug Administration regulations.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.